BlackRock Japan’s Genomic Health, Inc. GHDX Stock Holding History

BlackRock Japan’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$24K	Buy	812 +51	+7%	+$1.55K	﹤0.01%	1099
2016 Q3	$22K	Sell	761 -45	-6%	-$1.25K	﹤0.01%	1110
2016 Q2	$21K	Buy	806 +191	+31%	+$5.07K	﹤0.01%	1158
2016 Q1	$15K	Sell	615 -72	-10%	-$1.98K	﹤0.01%	1233
2015 Q4	$24K	Sell	687 -234	-25%	-$6.27K	﹤0.01%	1142
2015 Q3	$19K	Sell	921 -56	-6%	-$1.44K	﹤0.01%	1100
2015 Q2	$27K	Buy	+977	New	+$27.6K	﹤0.01%	1156
2013 Q4	–	Sell	-2,343	Closed	-$72K	–	1451
2013 Q3	$72K	Buy	+2,343	New	+$78.4K	﹤0.01%	1056

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock Japan's GHDX Position: Q4 2016 in Review

BlackRock Japan increased its Genomic Health, Inc. (GHDX) stake by 6.7% in Q4 2016, buying an estimated $1.55K and bringing the position to 812 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

BlackRock Japan first reported a position in GHDX in Q3 2013 and has held it in 8 quarters since. The position peaked at $72K in Q3 2013. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

BlackRock Japan held 812 shares of Genomic Health, Inc. worth $24K as of Q4 2016.
BlackRock Japan bought 51 Genomic Health, Inc. shares in Q4 2016, an estimated $1.55K.
Genomic Health, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1099 holding.
BlackRock Japan first reported a position in Genomic Health, Inc. in Q3 2013 and has held it in 8 quarters since.
BlackRock Japan's Genomic Health, Inc. position peaked at $72K in Q3 2013.
133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.